chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 minutes after vaccine received, patient reports feeling dizzy and lightheaded. Patient diaphoretic, skin cool and clammy to touch. Patient instructed to drink orange juice. No respiratory issues noted. Patient reports not eating anything today and he woke up at 9 am. Patient reports feeling nervous about vaccination before appointment. Patient observed for 30 minutes. Patient able to answer questions and follow commands appropriately. Patient advised to follow up with primary care provider and to call 911 if symptoms persist or experience respiratory distress. Patient instructed to have food/fluid and rest. Patient ambulatory and reports symptoms resolved about 10 minutes after drinking juice. Patient returning to work; manager and supervisor aware of patient's condition and notified to allow patient food/drink/rest as needed. Patient declined transportation to hospital. BP 110/70. HR 74.
Pfizer-BioNTech COVID-19 Vaccine  Dizziness, headache, generalized tingling.  No reactions to vaccines in the past.  Rapid response called, BP 187/104, O2 sat 100% on Room Air. nauseous, vomited 2-3 times. admitted to ER, discharged 3 hrs later, BP normal 122/73
Information has been received from a registered nurse concerning a female, pediatric patient, who was vaccinated with Gardasil, (lot not reported). Subsequently the patient experienced severe injection site pain. It was reported that the pain was in the muscle and started at the time of injections. The pain lasted for 2 days and then resolved. The patient was treated with warm compresses. The patient sought unspecified medical attention. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received SHINGRIX for prophylaxis. In May 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX on left arm. The patient experienced a very sore left arm for 10 days. The patient had denied permission to contact their physician and refused to provide date of birth.
Intense pain at the injection site followed by severe arm, shoulder pain. Decreased range of motion and ability to move without using other hand to list arm.
Patient reported that she had a brief loss of smell several days after her Moderna vaccine. She denied any other COVID symptoms. Smell returned after a day or so, and no treatment was required.  She just thought it was an odd symptom that she had not heard of anyone else getting, so wanted it reported.
DVT onset within 5 days of injection. No prior hx of DVTs or blood clots
has eczema; itches; fatigue; chills; slight pain at the injection site; muscle ache; headache; some sniffles; gets winded; anxiety; gastrointestinal (GI) issues; diarrhea; abdominal distress; abdominal cramping; hard to focus; slight confusion; forgetful; thinking Tuesday was Thursday; taking a shower takes a lot out of him; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL DISORDER (gastrointestinal (GI) issues), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (abdominal distress), ABDOMINAL PAIN (abdominal cramping) and DISTURBANCE IN ATTENTION (hard to focus) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concurrent medical conditions included Gastrointestinal disorder.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced ASTHENIA (taking a shower takes a lot out of him). On 08-May-2021, the patient experienced GASTROINTESTINAL DISORDER (gastrointestinal (GI) issues), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (abdominal distress), ABDOMINAL PAIN (abdominal cramping), DISTURBANCE IN ATTENTION (hard to focus), CONFUSIONAL STATE (slight confusion), MEMORY IMPAIRMENT (forgetful; thinking Tuesday was Thursday), RHINORRHOEA (some sniffles), DYSPNOEA (gets winded), ANXIETY (anxiety), FATIGUE (fatigue), CHILLS (chills), INJECTION SITE PAIN (slight pain at the injection site), MYALGIA (muscle ache) and HEADACHE (headache). On an unknown date, the patient experienced ECZEMA (has eczema) and PRURITUS (itches). At the time of the report, GASTROINTESTINAL DISORDER (gastrointestinal (GI) issues), DIARRHOEA (diarrhea), ABDOMINAL DISCOMFORT (abdominal distress), ABDOMINAL PAIN (abdominal cramping), DISTURBANCE IN ATTENTION (hard to focus), CONFUSIONAL STATE (slight confusion), MEMORY IMPAIRMENT (forgetful; thinking Tuesday was Thursday), ECZEMA (has eczema), RHINORRHOEA (some sniffles), DYSPNOEA (gets winded), ANXIETY (anxiety), ASTHENIA (taking a shower takes a lot out of him), PRURITUS (itches), FATIGUE (fatigue), CHILLS (chills), INJECTION SITE PAIN (slight pain at the injection site), MYALGIA (muscle ache) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient went to the hospital ER, tested negative for COVID-19 and had normal bloodwork. Treatment information not provided.
patient who was previously administered the 1st and 2nd doses of gardasil 9 (unknown dates), had missed patient's 3rd dose; no additional AE reported; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No patient's pertinent medical history, concurrent conditions, drug reactions or allergies, nor concomitant therapies were reported.     On an unknown date, the patient was vaccinated with her/his first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), (strength, dose, route, anatomical location, lot number and expiration date were not reported), for prophylaxis. On an unknown date, the patient was vaccinated with her/his second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), (strength, dose, route, anatomical location, lot number and expiration date were not reported), for prophylaxis. On an unknown date, the patient had missed her/his third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (inappropriate schedule of product administration). No additional adverse event reported.
11 year boy passed out suddenly after receiving vaccines on 1/17/09 @ around 6 pm.  I turned around to dispose of the needle, when he suddenly went to the floor bruised his forehead & upper lip ~1/4" bruise.  He was only out for few secs then recovered quickly & completely.  No treatment needed.
This case was reported by a lawyer and described the occurrence of fibromyalgia type symptoms in a 52 year old female pt who received Lymerix injection. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unk time after receiving Lymerix, the pt experienced fibromyalgia type symptoms along with neurologic symptoms including cognitive deficits, numbness and tingling with decreased perfusion on her SPECT (single photon emission computerized tomography) scan. Time to onset, treatment, and outcome were not reported.
Having a local reaction. Slightly swollen, raised, red and painful area at the injection site. Its probably 4 inches long and egg shaped. Applying warm packs and taking TYLENOL helps. Tired and had some chills.
29AUG 930PM pt gave a "yelp" began shaking, eyes rolled up, salivated 2-5min, went into a sleep like state; legs & arms jerky for 2 min; t100.1; 30AUG edema & tenderness @ site; yellow/brown skin; Dx poss viral infect, reactive cellulitis;
medical condition; 17 year old given vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of ILL-DEFINED DISORDER (medical condition) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 009A21A and 038C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old given vaccine.). On an unknown date, the patient experienced ILL-DEFINED DISORDER (medical condition) (seriousness criterion hospitalization). On 05-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year old given vaccine.) had resolved. At the time of the report, ILL-DEFINED DISORDER (medical condition) outcome was unknown.            Concomitant product use was not provided by the reporter. No treatment information was provided.  This report refers to a case of product administered to patient of inappropriate age for mRNA-1273 (lot 009A21A and 038C21A) with associated unspecified adverse event.  Very limited information regarding this event has been provided at this time. Further information regarding temporal association and indication for Hospitalization is necessary to assess causality.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age for mRNA-1273 (lot 009A21A and 038C21A) with associated unspecified adverse event.  Very limited information regarding this event has been provided at this time. Further information regarding temporal association and indication for Hospitalization is necessary to assess causality.
Starting 24 hours after vaccination: abdominal pain. Pulling, aching burning sensation.  Starting 52 hours after inoculation Temporary paralysis in arms and legs and rapid pulse for 1 hour followed by numbness and tingling in hands and feet. Hands and feet felt like ice cubes and could not get warm.  Weakness in legs continued. Total experience lasted 10 hours. CT scan and blood work done. CT scan showed new incidence of splenomegaly and decreased RBCs. Hospitalization via ambulance for 4.5 hours. Discharged with follow up CT in 6 months.  72 hours after vaccine the tingling continues in feet. Pressure in bilateral ears. Continuing abdominal pain.
Syncope, Fever, Tachycardia, Fatigue, Muscle Aches, Headaches, Weakness, Nausea, Dizziness, chills, sweats  Symptoms presented roughly 12 hours post admin.
30AUG96 2AM t104 w/mild sz taken to hosp & kept until 31AUG96;mom states fever cont to rise;pt went into gradual sz;pt irritable; pt exp jerking & had sz activity;pulse 160;t101.2;erythema of lt TM;neck rigid;dx feb sz;capillary heman
Two days after getting the second dose of the vaccine I woke up and I could not breathe for a short period of time. I was scheduled to see my doctor and he did some blood work. I was having trouble breathing when I ran. Six weeks later I was at the gym walking on the track and I could not breathe again. I went to the ER and it was discovered that I had Bilateral Multiple Emboli. I had blood clots in both lungs. They removed blood clots from both lungs and then I was hospitalized for three days. I have been advised to take Eliquis for the rest of my life. I was normally a runner and I have just returned to running again.
Extreme joint pain in arms & legs; Continued pain 10 to 12 on pain scale; Can't lift arms and hard to move legs to walk; Can't lift arms and hard to move legs to walk; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 68-years-old female patient (non-pregnant) received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on an unspecified date (Batch/Lot number and Expiration date was not reported) (at the age of 68-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included: blood pressure high, thyroid and drug allergy (Penicillin family drugs). Concomitant medications included losartan, levothyroxine, amlodipine and acetylsalicylic acid (ASPIRIN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since vaccination, the patient has not been tested for COVID-19. On 05Apr2021 11:15 the patient experienced extreme joint pain in arms & legs, can't lift arms and hard to move legs to walk and continued pain 10 to 12 on pain scale. It was reported that after shot arm sore. Then body aches and chills with night sweats. Went to Urgent Care, ER, and physician office. Received meds to pacify problem. Did not work. The problem continued to intensify. Was told it was not vaccine so did the 2nd shot which made symptoms worse. Extreme joint pain in arms & legs. Can't lift arms and hard to move legs to walk. Continued pain 10 to 12 on pain scale. The events resulted in Emergency room/department or urgent care/physician office visit. The patient received treatment with Pain medications and muscle relaxer and MRI (magnetic resonance imaging) was requested. The outcome of the events was not recovered.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Information has been received from a nurse referring to a patient of unknown age and gender.  On 28-JUN-2017, the patient was vaccinated with improperly stored VARIVAX (lot # M033212, expiration date 13-JUL-2018; dose and route were unknown) for prophylaxis. The vaccine reconstituted with properly stored sterile diluent (lot # and expiration date were unknown).     No adverse effects were reported. Data logger was involved. The vaccine was stored under -14 Celsius degree to -10 Celsius degree for 4 hours 3 minutes. Previous temperature excursion was -14 Celsius degree to -10 Celsius degree for 5 hours 13 minutes. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1707USA009387:
Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (has had shingles three times in his or her life).   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Sick). The outcome of the sickness was not reported.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     It was unknown if the company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 19-Mar-2023 The case was received from the patient via interactive digital media. The patient stated that none of them was as bad as the shingles vaccine, it made him or her sick. The follow-up could not be possible as no contact details were available.
April 12, 2021-Mild face swelling and light dizziness began about one hour after injection and lasted for about 2 hours.  I took a Zyrtec-D the morning of the injection so I think that helped keep the swelling under control.  April 15, 2021-around 6:00 pm I became very nauseous and dizzy.  The nausea subsided by the next morning but the dizziness has continued to this day.  Had to stay in bed all day April 17 and 18 due to dizziness.
Patient Became dizzy, fell forward, vomiting, not responsive to questions, slurry speech about 3 min after vaccine, Adm 0.3mg x1 EpiPen and 50mg IM Benadryl. EMS was called immediately. They arrived about 25 min later. She became responsive about 2 minutes after adm of the EpiPen. Patient was able to carry on a conversation and EMS recommended for her to proceed to the nearest ER as she did not wanted to be brought there per ambulance.
Mother noted rash on the patient's stomach approximately 1-2 hrs after vaccination. No itching and redness noted. States,"feels bumpy."
pt recvd vax; redness, pain, swelling, itching at site x 3 days;
pt felt extremely dizzy and sweaty, 911 was called. and they determined it was just the anxiousness of the pt that was manifested
Sometimes when she lays down she feels a sensation on the nerve; redness; she had a rash around her breast, behund her back; the injection site was red; she had pain the same day; This spontaneous case was reported by a patient and describes the occurrence of PAIN (she had pain the same day), SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve), ERYTHEMA (redness), RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Blood pressure high. Concomitant products included ESCITALOPRAM for Anxiety, METOPROLOL for Blood pressure high, FISH OIL (OMEGA 3 [FISH OIL]), MAGNESIUM CITRATE, POTASSIUM CITRATE (POTASSIUM MAGNESIUM CITRATE [MAGNESIUM CITRATE;POTASSIUM CITRATE]), VITAMIN C [ASCORBIC ACID], CALCIUM CARBONATE, VITAMIN D NOS (CALCIUM 600 WITH VITAMIN D), MULTIVITAMIN [VITAMINS NOS] and MINERALS for an unknown indication.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN (she had pain the same day). On 04-Apr-2021, the patient experienced ERYTHEMA (redness). 04-Apr-2021, the patient experienced RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red). On an unknown date, the patient experienced SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve). The patient was treated with GABAPENTIN at a dose of 100 mg and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form, q8h(3 to 5 days every 8 hrs). On 07-Apr-2021, ERYTHEMA (redness) had resolved. At the time of the report, PAIN (she had pain the same day), SENSORY DISTURBANCE (Sometimes when she lays down she feels a sensation on the nerve), RASH (she had a rash around her breast, behund her back) and VACCINATION SITE ERYTHEMA (the injection site was red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-045301 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up received contains significant information that event redness was recovered
left arm- swollen, red, warm to touch, painful- received vaccine on tues evening, wed woke up with symptoms, on Saturday- arm is more red and swollen.
Improper storage of product in use; No additional adverse effect reported, no further information provided; This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported.   On 30-NOV-2021, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) rHA (Lot# U002530 and expiration date 24-JUL-2022) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a temperature excursion of minus 14 degree Celsius to minus 10 degree Celsius (minus 13.6 Celsius) for 0 hours 42 minutes and 0 seconds and minus 14 degree Celsius to minus 10 degree Celsius (minus 13.5 Celsius) for 0 hours 45 minutes and 0 seconds. There was no previous temperature excursion. No additional adverse event reported, no further information provided. This is one of 8 reports from the same reporter.
Pt recvd vax & exp entire lt upper arm itchy, red, edematous & hot; pt was seen by MD;
pt rev vax & devel a chickenpox rash;the rash was reported as being very mild w/approx 20 lesions, 10 of which are pretty large;pt also had some itching, fever of up to 102;
Broke out with painful, itchy, blistery rashesall over both hands , palms, wrists , & forearms; Broke out with painful, itchy, blistery rashesall over both hands , palms, wrists , & forearms; Broke out with painful, itchy, blistery rashesall over both hands , palms, wrists , & forearms; Broke out with painful, itchy, blistery rashesall over both hands , palms, wrists , & forearms; This is a spontaneous report from a contactable healthcare professional, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 11Sep2021 at 15:15 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient's medical history reported was not applicable (as per source doc). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 13Sep2021, the patient broke out with painful, itchy, blistery rashes all over both hands, palms, wrists and forearms. It was reported that this led the patient to the urgent care. The event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with antibiotic cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event broke out with painful, itchy, blistery rashes all over both hands, palms, wrists and forearms was not resolved at the time of this report.
Lack of efficacy for the COVID vaccine.; COVID-19; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date the patient experienced lack of efficacy for the COVID vaccine; very mild symptoms several months after full vaccination confirmed by a rapid test. The patient underwent lab tests and procedures which included SARS-COV-2 test: positive on an unspecified date. The clinical outcome of the events was unknown.   Information on the lot/batch number has been requested.